img

Global Giant Cell Arteritis Treatment Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Giant Cell Arteritis Treatment Market Research Report 2024

Giant cell arteritis is also known as temporal arteritis, is a type of disease which causes inflammation of medium and large vessels that occurs only in individuals older than 50 years of age.
According to MRAResearch’s new survey, global Giant Cell Arteritis Treatment market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Giant Cell Arteritis Treatment market research.
Seasonal variations in the incidence of giant cell arteritis treatment suggest a possible infective origin however, current evidences are mixed. In a large epidemiologic study with a 12-year follow-up, there has been synchronous variation in the incidence of giant cell arteritis with epidemics of Mycoplasma pneumoniae, Chlamydia pneumonia and parvovirus B19.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Giant Cell Arteritis Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Johns Hopkins Hospital
Fortis Healthcare
American College of Rheumatology
Duke University Health System
Lahey Clinic Foundation
Segment by Type
Corticosteroid Therapy
Adjuvant Agents

Segment by Application


Hospitals
Clinics
ASCs
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Giant Cell Arteritis Treatment report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Giant Cell Arteritis Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Corticosteroid Therapy
1.2.3 Adjuvant Agents
1.3 Market by Application
1.3.1 Global Giant Cell Arteritis Treatment Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 ASCs
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Giant Cell Arteritis Treatment Market Perspective (2018-2033)
2.2 Giant Cell Arteritis Treatment Growth Trends by Region
2.2.1 Global Giant Cell Arteritis Treatment Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Giant Cell Arteritis Treatment Historic Market Size by Region (2018-2023)
2.2.3 Giant Cell Arteritis Treatment Forecasted Market Size by Region (2024-2033)
2.3 Giant Cell Arteritis Treatment Market Dynamics
2.3.1 Giant Cell Arteritis Treatment Industry Trends
2.3.2 Giant Cell Arteritis Treatment Market Drivers
2.3.3 Giant Cell Arteritis Treatment Market Challenges
2.3.4 Giant Cell Arteritis Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Giant Cell Arteritis Treatment Players by Revenue
3.1.1 Global Top Giant Cell Arteritis Treatment Players by Revenue (2018-2023)
3.1.2 Global Giant Cell Arteritis Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Giant Cell Arteritis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Giant Cell Arteritis Treatment Revenue
3.4 Global Giant Cell Arteritis Treatment Market Concentration Ratio
3.4.1 Global Giant Cell Arteritis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Giant Cell Arteritis Treatment Revenue in 2022
3.5 Giant Cell Arteritis Treatment Key Players Head office and Area Served
3.6 Key Players Giant Cell Arteritis Treatment Product Solution and Service
3.7 Date of Enter into Giant Cell Arteritis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Giant Cell Arteritis Treatment Breakdown Data by Type
4.1 Global Giant Cell Arteritis Treatment Historic Market Size by Type (2018-2023)
4.2 Global Giant Cell Arteritis Treatment Forecasted Market Size by Type (2024-2033)
5 Giant Cell Arteritis Treatment Breakdown Data by Application
5.1 Global Giant Cell Arteritis Treatment Historic Market Size by Application (2018-2023)
5.2 Global Giant Cell Arteritis Treatment Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Giant Cell Arteritis Treatment Market Size (2018-2033)
6.2 North America Giant Cell Arteritis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Giant Cell Arteritis Treatment Market Size by Country (2018-2023)
6.4 North America Giant Cell Arteritis Treatment Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Giant Cell Arteritis Treatment Market Size (2018-2033)
7.2 Europe Giant Cell Arteritis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Giant Cell Arteritis Treatment Market Size by Country (2018-2023)
7.4 Europe Giant Cell Arteritis Treatment Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Giant Cell Arteritis Treatment Market Size (2018-2033)
8.2 Asia-Pacific Giant Cell Arteritis Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Giant Cell Arteritis Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Giant Cell Arteritis Treatment Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Giant Cell Arteritis Treatment Market Size (2018-2033)
9.2 Latin America Giant Cell Arteritis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Giant Cell Arteritis Treatment Market Size by Country (2018-2023)
9.4 Latin America Giant Cell Arteritis Treatment Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Giant Cell Arteritis Treatment Market Size (2018-2033)
10.2 Middle East & Africa Giant Cell Arteritis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Giant Cell Arteritis Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Giant Cell Arteritis Treatment Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Johns Hopkins Hospital
11.1.1 Johns Hopkins Hospital Company Detail
11.1.2 Johns Hopkins Hospital Business Overview
11.1.3 Johns Hopkins Hospital Giant Cell Arteritis Treatment Introduction
11.1.4 Johns Hopkins Hospital Revenue in Giant Cell Arteritis Treatment Business (2018-2023)
11.1.5 Johns Hopkins Hospital Recent Development
11.2 Fortis Healthcare
11.2.1 Fortis Healthcare Company Detail
11.2.2 Fortis Healthcare Business Overview
11.2.3 Fortis Healthcare Giant Cell Arteritis Treatment Introduction
11.2.4 Fortis Healthcare Revenue in Giant Cell Arteritis Treatment Business (2018-2023)
11.2.5 Fortis Healthcare Recent Development
11.3 American College of Rheumatology
11.3.1 American College of Rheumatology Company Detail
11.3.2 American College of Rheumatology Business Overview
11.3.3 American College of Rheumatology Giant Cell Arteritis Treatment Introduction
11.3.4 American College of Rheumatology Revenue in Giant Cell Arteritis Treatment Business (2018-2023)
11.3.5 American College of Rheumatology Recent Development
11.4 Duke University Health System
11.4.1 Duke University Health System Company Detail
11.4.2 Duke University Health System Business Overview
11.4.3 Duke University Health System Giant Cell Arteritis Treatment Introduction
11.4.4 Duke University Health System Revenue in Giant Cell Arteritis Treatment Business (2018-2023)
11.4.5 Duke University Health System Recent Development
11.5 Lahey Clinic Foundation
11.5.1 Lahey Clinic Foundation Company Detail
11.5.2 Lahey Clinic Foundation Business Overview
11.5.3 Lahey Clinic Foundation Giant Cell Arteritis Treatment Introduction
11.5.4 Lahey Clinic Foundation Revenue in Giant Cell Arteritis Treatment Business (2018-2023)
11.5.5 Lahey Clinic Foundation Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Giant Cell Arteritis Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Corticosteroid Therapy
Table 3. Key Players of Adjuvant Agents
Table 4. Global Giant Cell Arteritis Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Giant Cell Arteritis Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Giant Cell Arteritis Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Giant Cell Arteritis Treatment Market Share by Region (2018-2023)
Table 8. Global Giant Cell Arteritis Treatment Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Giant Cell Arteritis Treatment Market Share by Region (2024-2033)
Table 10. Giant Cell Arteritis Treatment Market Trends
Table 11. Giant Cell Arteritis Treatment Market Drivers
Table 12. Giant Cell Arteritis Treatment Market Challenges
Table 13. Giant Cell Arteritis Treatment Market Restraints
Table 14. Global Giant Cell Arteritis Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Giant Cell Arteritis Treatment Market Share by Players (2018-2023)
Table 16. Global Top Giant Cell Arteritis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Giant Cell Arteritis Treatment as of 2022)
Table 17. Ranking of Global Top Giant Cell Arteritis Treatment Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Giant Cell Arteritis Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Giant Cell Arteritis Treatment Product Solution and Service
Table 21. Date of Enter into Giant Cell Arteritis Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Giant Cell Arteritis Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Giant Cell Arteritis Treatment Revenue Market Share by Type (2018-2023)
Table 25. Global Giant Cell Arteritis Treatment Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Giant Cell Arteritis Treatment Revenue Market Share by Type (2024-2033)
Table 27. Global Giant Cell Arteritis Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Giant Cell Arteritis Treatment Revenue Market Share by Application (2018-2023)
Table 29. Global Giant Cell Arteritis Treatment Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Giant Cell Arteritis Treatment Revenue Market Share by Application (2024-2033)
Table 31. North America Giant Cell Arteritis Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Giant Cell Arteritis Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Giant Cell Arteritis Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Giant Cell Arteritis Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Giant Cell Arteritis Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Giant Cell Arteritis Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Giant Cell Arteritis Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Giant Cell Arteritis Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Giant Cell Arteritis Treatment Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Giant Cell Arteritis Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Giant Cell Arteritis Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Giant Cell Arteritis Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Giant Cell Arteritis Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Giant Cell Arteritis Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Giant Cell Arteritis Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 46. Johns Hopkins Hospital Company Detail
Table 47. Johns Hopkins Hospital Business Overview
Table 48. Johns Hopkins Hospital Giant Cell Arteritis Treatment Product
Table 49. Johns Hopkins Hospital Revenue in Giant Cell Arteritis Treatment Business (2018-2023) & (US$ Million)
Table 50. Johns Hopkins Hospital Recent Development
Table 51. Fortis Healthcare Company Detail
Table 52. Fortis Healthcare Business Overview
Table 53. Fortis Healthcare Giant Cell Arteritis Treatment Product
Table 54. Fortis Healthcare Revenue in Giant Cell Arteritis Treatment Business (2018-2023) & (US$ Million)
Table 55. Fortis Healthcare Recent Development
Table 56. American College of Rheumatology Company Detail
Table 57. American College of Rheumatology Business Overview
Table 58. American College of Rheumatology Giant Cell Arteritis Treatment Product
Table 59. American College of Rheumatology Revenue in Giant Cell Arteritis Treatment Business (2018-2023) & (US$ Million)
Table 60. American College of Rheumatology Recent Development
Table 61. Duke University Health System Company Detail
Table 62. Duke University Health System Business Overview
Table 63. Duke University Health System Giant Cell Arteritis Treatment Product
Table 64. Duke University Health System Revenue in Giant Cell Arteritis Treatment Business (2018-2023) & (US$ Million)
Table 65. Duke University Health System Recent Development
Table 66. Lahey Clinic Foundation Company Detail
Table 67. Lahey Clinic Foundation Business Overview
Table 68. Lahey Clinic Foundation Giant Cell Arteritis Treatment Product
Table 69. Lahey Clinic Foundation Revenue in Giant Cell Arteritis Treatment Business (2018-2023) & (US$ Million)
Table 70. Lahey Clinic Foundation Recent Development
Table 71. Research Programs/Design for This Report
Table 72. Key Data Information from Secondary Sources
Table 73. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Giant Cell Arteritis Treatment Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Giant Cell Arteritis Treatment Market Share by Type: 2022 VS 2033
Figure 3. Corticosteroid Therapy Features
Figure 4. Adjuvant Agents Features
Figure 5. Global Giant Cell Arteritis Treatment Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Giant Cell Arteritis Treatment Market Share by Application: 2022 VS 2033
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. ASCs Case Studies
Figure 10. Others Case Studies
Figure 11. Giant Cell Arteritis Treatment Report Years Considered
Figure 12. Global Giant Cell Arteritis Treatment Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global Giant Cell Arteritis Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global Giant Cell Arteritis Treatment Market Share by Region: 2022 VS 2033
Figure 15. Global Giant Cell Arteritis Treatment Market Share by Players in 2022
Figure 16. Global Top Giant Cell Arteritis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Giant Cell Arteritis Treatment as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Giant Cell Arteritis Treatment Revenue in 2022
Figure 18. North America Giant Cell Arteritis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America Giant Cell Arteritis Treatment Market Share by Country (2018-2033)
Figure 20. United States Giant Cell Arteritis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Canada Giant Cell Arteritis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Giant Cell Arteritis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Giant Cell Arteritis Treatment Market Share by Country (2018-2033)
Figure 24. Germany Giant Cell Arteritis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. France Giant Cell Arteritis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. U.K. Giant Cell Arteritis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Italy Giant Cell Arteritis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Russia Giant Cell Arteritis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Nordic Countries Giant Cell Arteritis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Giant Cell Arteritis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Giant Cell Arteritis Treatment Market Share by Region (2018-2033)
Figure 32. China Giant Cell Arteritis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Japan Giant Cell Arteritis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. South Korea Giant Cell Arteritis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Southeast Asia Giant Cell Arteritis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. India Giant Cell Arteritis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Australia Giant Cell Arteritis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Giant Cell Arteritis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Giant Cell Arteritis Treatment Market Share by Country (2018-2033)
Figure 40. Mexico Giant Cell Arteritis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Brazil Giant Cell Arteritis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Giant Cell Arteritis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Giant Cell Arteritis Treatment Market Share by Country (2018-2033)
Figure 44. Turkey Giant Cell Arteritis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Saudi Arabia Giant Cell Arteritis Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Johns Hopkins Hospital Revenue Growth Rate in Giant Cell Arteritis Treatment Business (2018-2023)
Figure 47. Fortis Healthcare Revenue Growth Rate in Giant Cell Arteritis Treatment Business (2018-2023)
Figure 48. American College of Rheumatology Revenue Growth Rate in Giant Cell Arteritis Treatment Business (2018-2023)
Figure 49. Duke University Health System Revenue Growth Rate in Giant Cell Arteritis Treatment Business (2018-2023)
Figure 50. Lahey Clinic Foundation Revenue Growth Rate in Giant Cell Arteritis Treatment Business (2018-2023)
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed